Naltrexone Treatment of Alcohol Abuse in Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
SchizophreniaMental DisordersAlcohol AbuseAlcoholismAlcohol-related Disorders
Interventions
DRUG

Naltrexone or Placebo

Naltrexone or Placebo 50 mg per day

Trial Locations (4)

13203

St. Joseph's Mental Health Services, Syracuse

13210

Hutchings Psychiatric Center, Syracuse

SUNY Upstate Medical University, Syracuse

Veterans Administration Healthcare Center, Syracuse

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

State University of New York - Upstate Medical University

OTHER

NCT00145847 - Naltrexone Treatment of Alcohol Abuse in Schizophrenia | Biotech Hunter | Biotech Hunter